Infectious Diseases
Conference Coverage
Cefazolin outperforms nafcillin for staphylococcal bacteremia
Key clinical point: The time is nigh for cefazolin to replace nafcillin as first-line therapy for methicillin-susceptible Staphylococcus aureus...
Conference Coverage
Underweight patients showed greater mortality with gram-negative bacteremia
Patients hospitalized for gram-negative bacteremia who weighed more than 70 kg had improved 30-day mortality, compared with those who weighed 70...
Conference Coverage
Smoother orthopedic implants may minimize bacterial adherence
Rough materials used for orthopedic implants, such as cobalt chromium and titanium, increased bacterial adherence, while smoother materials such...
Conference Coverage
Prolonged sepsis increased inpatient mortality risk
The longer patients have sepsis, the more likely they are to die while in the hospital, a retrospective, single-center study showed.
News
Half of pregnant women got the flu vaccine in 2014-15 season
Among women who were pregnant at any time from October 2014 through January 2015, 50.3% received influenza vaccination before or during pregnancy...
Conference Coverage
VIDEO: CDC urges flu shots for all eligible patients
The CDC and National Foundation of Infectious Diseases hosted a press conference to talk about the important of getting influenza vaccinations for...
News
Uptick in health care workers getting flu shots in 2014-2015 season
Conference Coverage
Internet-based service increases access to STI testing
Negative results are made available through GetCheckedOnline.com, but individuals who have positive results are asked to contact the clinic to...
News
CDC details nonmedical vaccination exemptions
Altogether, 46 states and D.C. reported nonmedical exemption data for 3,829,686 current kindergartners.
Conference Coverage
Point-of-care chlamydia, gonorrhea assay as good as lab test
A molecular-based, point-of-care test for chlamydia and gonorrhea has shown similar accuracy to laboratory-based testing in a primary care setting...
Conference Coverage
Azithromycin and doxycycline effective for urogenital chlamydia*
Azithromycin has been shown in a randomized clinical trial to be noninferior to doxycycline in the treatment of chlamydia.